Universal Hepatitis B Vaccination at Birth—Risks of Revising the Recommendation

This Viewpoint from infectious disease experts cautions about the consequences of rescinding the ACIP policy to immunize all newborns against hepatitis B.

Corresponding Author: Rochelle Walensky, MD, MPH, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114 (Rochelle.Walensky.MD@gmail.com).

Link to the article in your story

We encourage you to link out to this article in your story using the link below. It includes an access token that will give free access to the article for your readers up to one year after publication. (The link will be live after the article publishes and embargo is lifted.)

Please see the article for additional information, including full author list, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

Need more information? Contact us.